Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract manufactures have a duty to engage with the ...

Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...

Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare ...

Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.

Daiichi Sankyo and AstraZeneca's ENHERTU has been conditionally approved by China's NMPA for a specific type of NSCLC.

Data from the Rainbowfish trial was presented at the World Muscle Society (WMS) Congress 2024 in Prague, Czech Republic.

Capricor Therapeutics plans to apply for FDA approval for its DMD cell therapy, deramiocel, by the end of 2024.